XML 49 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 94 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Grant revenue, research and development program revenue and other revenue $ 1,124 $ 614 $ 8,273
Total revenues 3,543 14,872 110,116
Cost of goods sold 2,048 15,010 107,574
Gross loss (960) (138) (831)
Operating expenses      
Research and development 4,976 4,955 81,626
Selling, general and administrative 6,950 13,127 121,256
Other operating expenses     1,248
Total operating expenses 11,926 18,082 204,130
Loss from operations (12,886) (18,220) (204,961)
Other income (expense)      
Interest expense (3,276) (1,087) (18,193)
(Loss) gain from change in fair value of embedded derivative (1,330)   15,670
Loss on extinguishment of debt (926)   (926)
Other income 48   832
Change in fair value of warrant liabilities     (2,852)
Total other expense (5,484) (1,087) (5,469)
Net loss (18,370) (19,307) (210,430)
Deemed dividend - amortization of beneficial conversion feature on Series D-1 preferred stock     (3,872)
Net loss attributable to Gevo, Inc. common stockholders (18,370) (19,307) (214,302)
Net loss per share attributable to Gevo, Inc. common stockholders - basic and diluted $ (0.45) $ (0.74)  
Weighted-average number of common shares outstanding - basic and diluted 40,996,922 26,186,133  
Ethanol
     
Sales   14,258 98,415
Corn
     
Sales 2,419   3,428
Cost of goods sold $ 2,455   $ 3,373